Browsing Tag
Iain Dukes
1 post
Can the Barinthus–Clywedog merger reshape diabetes and autoimmune drug pipelines?
Barinthus Biotherapeutics merges with Clywedog Therapeutics in an all-stock deal. Explore the impact on diabetes, celiac drug pipelines, and BRNS stock.